SPF
DGX icon

South Plains Financial’s Quest Diagnostics DGX Stock Holding History

South Plains Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.8K Buy
198
+20
+11% +$3.89K 0.02% 174
2025
Q4 		$30.9K Hold
178
– – 0.02% 195
2025
Q3 		$33.9K Buy
178
+46
+35% +$8.16K 0.02% 175
2025
Q2 		$23.7K Buy
132
+98
+288% +$17K 0.02% 174
2025
Q1 		$5.75K Buy
+34
New +$5.58K ﹤0.01% 201

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

South Plains Financial's DGX Position: Q1 2026 in Review

South Plains Financial increased its Quest Diagnostics (DGX) stake by 11% in Q1 2026, buying an estimated $3.89K and bringing the position to 198 shares worth $38.8K. The position accounts for 0.02% of the portfolio, ranked #174.

South Plains Financial first reported a position in DGX in Q1 2025 and has held it in 5 quarters since. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • South Plains Financial held 198 shares of Quest Diagnostics worth $38.8K as of Q1 2026.
  • South Plains Financial bought 20 Quest Diagnostics shares in Q1 2026, an estimated $3.89K.
  • Quest Diagnostics made up 0.02% of South Plains Financial's portfolio in Q1 2026, its #174 holding.
  • South Plains Financial first reported a position in Quest Diagnostics in Q1 2025 and has held it in 5 quarters since.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on South Plains Financial's 13F filing for Q1 2026, filed 13 May 2026.